Perspective Therapeutics, Inc. — Director's Dealing 2018

Jun 19, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2018-06-04

Reporting Person: Woods Lori A (Director, Interim CEO)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (right to buy)	$0.6050	2027-06-27	Common Stock (100000)		Direct

Footnotes

F1: 25% vested as of 6/27/2017, and the remaining 75% will vest over the next three (3) years, commencing on 6/27/2018, until fully vested.